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TREK-1 Channel Expression in
Smooth Muscle as a Target for
Regulating Murine Intestinal
Contractility: Therapeutic
Implications for Motility Disorders
Ruolin Ma, Mohsen Seifi, Maria Papanikolaou, James F. Brown, Jerome D. Swinny and
Anthony Lewis*
School of Pharmacy and Biomedical Sciences, Institute of Biological and Biomedical Sciences, University of Portsmouth,
Portsmouth, United Kingdom
Gastrointestinal (GI) motility disorders such as irritable bowel syndrome (IBS) can
occur when coordinated smooth muscle contractility is disrupted. Potassium (K+)
channels regulate GI smooth muscle tone and are key to GI tract relaxation, but
their molecular and functional phenotypes are poorly described. Here we define the
expression and functional roles of mechano-gated K2P channels in mouse ileum and
colon. Expression and distribution of the K2P channel family were investigated using
quantitative RT-PCR (qPCR), immunohistochemistry and confocal microscopy. The
contribution of mechano-gated K2P channels to mouse intestinal muscle tension was
studied pharmacologically using organ bath. Multiple K2P gene transcripts were detected
in mouse ileum and colon whole tissue preparations. Immunohistochemistry confirmed
TREK-1 expression was smooth muscle specific in both ileum and colon, whereas
TREK-2 and TRAAK channels were detected in enteric neurons but not smooth muscle.
In organ bath, mechano-gated K2P channel activators (Riluzole, BL-1249, flufenamic
acid, and cinnamyl 1-3,4-dihydroxy-alpha-cyanocinnamate) induced relaxation of KCl
and CCh pre-contracted ileum and colon tissues and reduced the amplitude of
spontaneous contractions. These data reveal the specific expression of mechano-gated
K2P channels in mouse ileum and colon tissues and highlight TREK-1, a smooth muscle
specific K2P channel in GI tract, as a potential therapeutic target for combating motility
pathologies arising from hyper-contractility.
Keywords: TREK-1, smooth muscle, ileum, colon, K2P channels, contractility, motility
Abbreviations: 4-AP, 4-aminopyridine; BKCa, Large conductance calcium-activated potassium channel; BL-1249, (5,6,7,8-
tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine; CCh, Carbachol; CDC, Cinnamyl-3,4-dihydroxy-α-
cyanocinnamate; DIC, Differential interference contrast; FFA, Flufenamic acid; hERG, Human ether-a-go-go potassium
channel; IBS, Irritable Bowel Syndrome; K1P, Single pore-domain potassium; K2P, Two pore-domain potassium; NOS, Nitric
oxide synthase; qPCR, Quantitative Polymerase Chain Reaction; SDK, Stretch-dependent potassium channel; TBS-Tx, Tris
Buffer Saline containing Triton X-100; TEA, Tetraethylammonium; TTX, Tetrodotoxin; VDCC, Voltage-dependent calcium
channel.
Ma et al. TREK-1 in GI Tract Smooth Muscle
INTRODUCTION
Gastrointestinal motility is a highly complex physiological
process involving the coordinated contractions of the tunica
muscularis, a layer of the outer wall of the alimentary canal
formed of two sheets of circularly and longitudinally orientated
smooth muscle cells. Disruption to the natural rhythm of
intestinal contractions can lead to common hypo- or hyper-
motility pathologies such as irritable bowel syndrome (IBS)
(Beyder and Farrugia, 2012).
The process of smooth muscle cell excitation-contraction
coupling occurs predominantly via calcium influx through
plasma membrane voltage-dependent calcium channels
(VDCC). The activity of VDCC is intimately linked to cell
membrane potential (Sanders, 2008; Jepps et al., 2009), which is
set primarily by potassium-selective (K+) channels (Koh et al.,
2012). K+ channels are formed from multimers of subunits
containing either a single (K1P) or tandem (K2P) pore domain
structure. A multitude of voltage-dependent and voltage-
independent K1P channels have been shown to be expressed,
both molecularly and functionally, in smooth muscles of the
gastrointestinal tract (for review see Koh et al., 2012).
In contrast, our understanding of the expression of the
voltage-independent K2P channel subfamily in gastrointestinal
tissues is limited. K2P channels contribute to the generic
background potassium conductance in many cell types
(Feliciangeli et al., 2015) and can be regulated by a plethora
of endogenous and environmental cues including changes
to oxygen, temperature, and pH levels or membrane tension
(Maingret et al., 1999; Lewis et al., 2001; Kang et al., 2005).
A functional role in myogenic regulation has, however been
proposed (for review see Sanders and Koh, 2006). First described
as a stretch-dependent potassium (SDK) conductance in mouse
colonic smooth muscle cells, it bears all the biophysical hallmarks
of a mechano-gated TREK-like channel including sensitivity to
mechanical stretch, insensitivity to tetraethylammonium (TEA)
and 4-aminopyridine (4-AP) and regulation by nitric oxide (Koh
and Sanders, 2001; Koh et al., 2001; Park et al., 2005). However,
direct pharmacological validation of TREK K2P channels in
gastrointestinal smooth muscle is currently lacking.
Here we use a combined molecular, protein and
pharmacological approach to study the expression of K2P
channels in both ileum and colon of mouse, with focus on the
specific distribution and functional role of the mechano-gated
subfamily members TREK-1, TREK-2, and TRAAK.
METHODS
Experimental Animals
All procedures involving experimental animals were approved
by the Animal Welfare and Ethics Review Committee of
the University of Portsmouth and were performed in
accordance with regulations issued by the Home Office of
the United Kingdom under the Animals (Scientific Procedures)
Act, 1986. All animals were housed in standard plastic cages,
on sawdust bedding in an air-conditioned room at 22 ± 1◦C
under lighting controls with 12 h light and dark cycles. Standard
mouse chow and tap water were provided ad libitum. Adult
(2–3 months) wild type (WT) C57BL/6J mice (Charles River
Laboratories, Margate, UK) of either sex were used throughout
the study.
Quantitative RT-PCR
Quantitative reverse transcription-PCR (qRT-PCR) was used to
define the expression profiles of K2P transcripts from ileum and
colon tissue sections, as previously described (Papanikolaou et al.,
2017). Custom primers (Primerdesign Ltd, Chandlers Ford, UK)
were designed to target the 14 identified mouse K2P genes (mice
lack the KCNK17 gene encoding for TALK-2), as detailed in
Supplementary Table 1. Mice (n = 3) were killed by cervical
dislocation and the segments of the ileum and colon manually
dissected and snap frozen in liquid nitrogen. Frozen tissue was
homogenized in RNase-free and sterile conditions and RNA
extracted using an RNeasy Midi Kit (Qiagen, Manchester, UK)
following the manufacturer’s protocol. RNA was then reverse
transcribed into single-stranded cDNAusing the RT2 First Strand
Kit (Qiagen, Manchester, UK). Quantity and quality of both RNA
and cDNA was assessed spectrophotometrically. Quantitative
RT-PCR (qPCR) was conducted in triplicate from generated
cDNA libraries using SYBR green qPCR Mastermix (Qiagen,
Manchester, UK) on Roche Lightcycler 96 (Roche, Burgess Hill,
UK). Relative gene expression was determined using the 2−1Ct
method vs. GAPDHwhich was identified as the most appropriate
housekeeping gene using the Normfinder algorithm (Andersen
et al., 2004) and the standard deviation (SD) method (Mane et al.,
2008).
Tissue Preparation for
Immunohistochemistry
Mice were anesthetized with isoflurane and pentobarbitone
(1.25mg kg−1 bodyweight, i.p.). Animals were transcardially
perfused using a fixative containing 1% paraformaldehyde and
15% v/v saturated picric acid in 0.1M phosphate buffer (pH
7.4), as previously described (Seifi et al., 2014). After perfusion,
the ileum and colon were surgically removed and post-fixed
in the same fixative overnight at 4◦C, before washing in
0.1M phosphate buffer to clear residual fixative. Whole-mount
preparations of the longitudinal muscle-myenteric plexus (MP)
and circular muscle-submucosal plexus were obtained using a
dissecting microscope and fine forceps, and stored in 0.1M
phosphate buffer containing 0.05% sodium azide at 4◦C until use.
Immunohistochemistry
Specificity of primary antibodies has been confirmed previously,
as detailed in Supplementary Table 2, and therefore was not re-
examined here. Non-specific binding of secondary antibodies
was blocked by incubating the tissue with 20% normal horse
serum, diluted in Tris buffer saline containing 0.3% Triton X-100
(TBS-Tx) for 2 h at room temperature. Tissue sections were
then incubated with cocktails of primary antibodies (listed in
Supplementary Table 2), diluted in TBS-Tx and 20% normal
horse serum, overnight at 4◦C on a rotating platform. Tissues
were then washed with TBS-Tx three times and incubated in
a mixture of appropriate conjugated secondary antibodies (see
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Supplementary Table 2) for 2 h at room temperature. Tissues
were washed three times in TBS-Tx and mounted on glass slides
in Mowiol mounting medium (Polysciences, Hirschberg an der
Bergstrasse, Germany) under a cover slip. Secondary antibody
specificity was assessed by omitting the primary antibodies in the
incubation sequence. To confirm the absence of cross reactivity
between IgGs in double and triple immunolabeling experiments,
some sections were processed using only a single primary
antibody with the full complement of secondary antibodies.
Immunohistochemical labeling was determined by confocal
microscopy based on 3–4 sections for each antibody from n = 3
animals.
Image Capture and Analysis
Sections were examined with a confocal laser-scanning
microscope (LSM710; Zeiss) using either a Plan Apochromatic
40x DIC oil objective (NA 1.3; pixel size 0.29µm) or a Plan
Apochromatic 63x oil objective (NA 1.4; pixel size 0.13µm).
Z-stacks were used for routine evaluation of labeling. All images
shown represent a single optical section. Images were acquired
using sequential acquisition of different channels to avoid
crossover between fluorophores, with the pinholes adjusted to
one airy unit for all channels. Identical settings were used to
image negative controls. Images were processed using Zen2009
Light Edition software (Zeiss, Cambridge, UK) and exported
into Adobe Photoshop CC 2015.5. Only brightness and contrast
were adjusted for the whole frame, and no part of a frame was
enhanced or modified in any way.
Organ Bath Pharmacology
Mice were killed by cervical dislocation and the distal ileum
and colon removed and immediately transferred to Krebs’
solution containing the following (in mM): 118 NaCl, 4.7 KCl,
1.2 KH2PO4, 25 NaHCO3, 11 glucose, 1.2 MgSO4, 2.5 CaCl2.
The intraluminal contents were gently removed by flushing
with the Kreb’s solution. Segments of ileum and colon (∼2–
3 cm) from the same animal were longitudinally mounted in
parallel on aerators and suspended by cotton thread from force
transducers (Harvard, UK) and both submerged in 10ml organ
bath chambers filled with pre-warmed Kreb’s solution (32◦C for
pre-contracted studies/37◦C to measure spontaneous activity),
and gassed with carbogen (95% O2 and 5% CO2). Changes in
tension at the transducer were processed through an amplifier
(Harvard, Cambridge, UK) and recorded by a dedicated data
acquisition system (Power LabChart7, AD Instruments, Oxford,
UK). The apparatus was calibrated and tissues placed under 1 g
of resting tension and allowed to equilibrate for at least 20min.
Viability of ileum and colon tissues was assessed in parallel
by exposure to the parasympathomimetic carbachol (CCh)
at concentrations ranging from 10−9 to 10−4 M. Responses
to K2P channel modulators were performed after exposure
to submaximal concentrations of CCh or 60mM KCl and
quantified by assessingmaximum changes in steady state tension.
In separate experiments, spontaneous contractile activity was
quantified. Tissues were prepared as described above. After stable
baselines were established, changes in the force and frequency
induced by K2P modulators were recorded and quantified over
5min periods pre- and post-drug application.
Data and Statistical Analysis
Statistical analyses and graphical evaluations were performed
with Prism 7.0 (GraphPad, Inc., La Jolla, CA, USA). Figure
legends provide n values and specific statistical tests performed.
For all analysis, n values represent animal numbers. All data
are presented as the arithmetic mean ± SEM unless stated
otherwise. Changes in tension were normalized to steady-state
pre-contracted tension and are reported as percent, and was
used to control for natural biological variation in contraction
amplitudes of the tissues. Curve fitting for determination of IC50
values was performed using the non-linear regression normalized
response function. Statistical comparisons were made using
either Student’s t-test (paired or unpaired where appropriate)
or two-way ANOVA (not repeated measures), followed by the
Bonferroni post-hoc test. A p < 0.05 was considered statistically
significant.
Drugs
All drugs and chemical were purchased from Sigma Aldrich
(Gillingham, UK) unless otherwise stated. Riluzole, BL-1249,
Flufenamic acid (FFA), and Cinnamyl-3,4-dihydroxy-α-
cyanocinnamate (CDC) were dissolved in DMSO. DMSO final
bath concentrations did not exceed 0.1% and had no significant
effect on measured tension of the amplitude or frequency of
spontaneous muscle contractions (data not shown).
RESULTS
K2P Channel Genes Show Differential
Expression in Whole Ileum and Colon
Tissues of Mouse
The goal of the current study was to assess the specific
distribution and functional contribution of mechano-gated
K2P channels in ileum and colon of the mouse. However, a
comprehensive assessment of K2P channel expression is currently
lacking. We therefore first quantified the expression levels of
all known mouse K2P channel genes by real-time PCR (qPCR)
analysis, normalized against the housekeeping gene GAPDH by
the comparative 2−1Ct method. qPCR analysis revealed variable
expression of multiple K2P channel mRNA transcripts in whole
tissue of wild type mouse ileum and colon (Figure 1). Of the
14 K2P channel subunit genes analyzed, both TWIK-1 (KCNK1)
and TASK-2 (KCNK5) displayed the highest relative transcript
level expression in both whole ileum and colon, an order of
magnitude higher than the next most abundant transcripts
TREK-1 (KCNK2, ileum) and TWIK-2 (KCNK6, colon). In
both tissues, gene transcripts encoding for TRAAK (KCNK4),
TASK-3 (KCNK9), TREK-2 (KCNK10), THIK-2 (KCNK12),
TASK-5 (KCNK15), and TALK-1 (KCNK16) appeared barely
detectable when normalized to housekeeping gene GAPDH and
may be suggestive of cell specific expression patterns or broad
tissue expression at low levels. Transcript encoding for TRESK
(KCNK18) was not detected in either ileum or colon as concluded
from a lack of a measurable Ct value after 40 cycles of PCR.
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FIGURE 1 | Differential expression of K2P subtype transcripts in the mouse ileum and colon. Quantitative, real-time PCR performed on lysates of acutely isolated
ileum (A) and colon (B) from wild type mice. Data are expressed as relative mRNA levels (2−1Ct) compared to the housekeeping gene GAPDH (mean ± SEM, n = 3).
TWIK-1, (KCNK1), and TASK-2 (KCNK5) displayed the highest relative expression levels in both ileum and colon (insets). Rank order of detectable expression was as
follows, in ileum; TWIK-1 (KCNK1) > TASK-2 (KCNK5) > TREK-1 (KCNK2) > TASK-1 (KCNK3) > TWIK-2 (KCNK6) > THIK-1 (KCNK13) > K2P 7.1 (KCNK7), and in
colon; TWIK-1 (KCNK1) > TASK-2 (KCNK5) > TWIK-2 (KCNK6) > TASK-1 (KCNK3) > TREK-1 (KCNK2) > THIK-1 (KCNK13) > K2P 7.1 (KCNK7).
TWIK-1 and TASK-2 Channel Proteins
Display Broad Distribution Patterns in
Mouse Ileum and Colon
Given their abundant transcript levels we determined the
precise cellular location TWIK-1 and TASK-2 channels
within the mouse intestine, using immunohistochemistry and
confocal microscopy. Expression of TWIK-1 was detected
on plasma membranes and in cytoplasmic compartments of
NOS-immuno-positive MP neurons of both mouse ileum
and colon (Figures 2A1,B1). Immunoreactivity for TWIK-
1 was also observed in the longitudinal smooth muscle
(LM) cells in both ileum and colon, as demonstrated by co-
localization with the smooth muscle cell marker α-actinin
(Figures 2A2,B2). Immunoreactivity for the TASK-2 channel
was significantly enriched in the cell membranes of NOS-
immunopositive MP neurons (Figures 2C1,D1), but was
not detectable in LM cells of either mouse ileum or colon
(Figures 2C2,D2). These data indicate that TWIK-1 and
TASK-2 channels are widely distributed across neuronal and
smooth muscle tissues and correlates with the abundant
transcript expression observed in both ileum and colon.
However, a current lack of specific pharmacological tools for
TWIK-1 and TASK-2 prevents further detailed functional
studies.
TREK-1 Protein Shows Smooth Muscle
Specific Expression in Mouse GI Tract
Our qPCR data indicate that TREK subfamily channel gene
transcripts (TREK-1, TREK-2, and TRAAK) are present in
both mouse ileum and colon, however, their levels may be
suggestive of cell specific expression patterns. Therefore, we
utilized K2P channel specific antibody immunolabeling to
characterize the distribution of TREK family channels in muscle
and nervous tissue of the mouse GI tract. For consistency with
organ bath studies we have focused on expression profiles in
LM layers and MP neurons, but duplicate experiments were
performed in circular smooth muscle layers and neighboring
submucosal plexus neurons, as illustrated in Supplementary
Figure 1.
Immunoreactivity for the TREK-1 channel indicated it
was widely distributed across longitudinal (Figures 3A,B)
and circular (Supplementary Figure 1) smooth muscle tissue
in both ileum and colon, as visualized by overlapping
immunoreactivity with the smooth muscle cell marker α-actinin.
In contrast, TREK-1 immunoreactivity was not detected in NOS-
immunopositive MP neurons and submucosal plexus neurons
(Figures 3C,D and Supplementary Figure 1).
TREK-2 and TRAAK Proteins Are Not
Expressed in GI Tract Smooth Muscle
In both mouse ileum and colon, we were unable to detect
immunoreactivity for the TREK-2 channel in LM cell
layers (Figures 4A,B). In contrast, strong TREK-2 labeling
was observed within NOS-immunopositive MP neurons
(Figures 4C,D). Moreover, TREK-2 was also detected in a
number of non-NOS enteric neurons and cholinergic neurons
(Figures 4C,D) as visualized by co-labeling with the acetylcholine
synthesizing enzyme, choline acetyltransferase (ChAT) and the
calcium binding protein, calretinin (Supplementary Figure 2).
Similar to TREK-2, we could find no evidence for TRAAK
expression in LM cells in either mouse ileum or colon
(Figures 5A,B). The pattern of TRAAK channel labeling
observed in the MP neurons of ileum and colon was analogous
to that observed for TREK-2, displaying a wide distribution
across both NOS-immunopositive and NOS-immunonegative
cell types of MPs (Figures 5C,D).
Collectively, these data reveal the tissue specific
distribution of TREK subfamily K2P channels in mouse
ileum and colon, with TREK-1 confined to smooth muscle
and TREK-2 and TRAAK channels displaying neuronal
expression with no detectable expression in smooth
muscle.
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FIGURE 2 | TWIK-1 and TASK-2 channels are distributed in myenteric plexus inhibitory neurons and longitudinal smooth muscle layers of the mouse ileum and colon.
Panels show overlays of cell specific markers (green) and individual K2P channel markers (red) throughout. (A1,B1) show overlays for NOS immunoreactive myenteric
plexus neurons and the TWIK-1 channel in ileum and colon respectively. TWIK-1 labeling was cytoplasmic and can be observed in both NOS-positive and
NOS-negative enteric neurons. Within the longitudinal smooth muscle layer, TWIK-1 channels were distributed in α-actinin-immunopositive smooth muscles in both
ileum (A2) and colon (B2). (C1,D1) show overlays for NOS immunoreactive myenteric plexus neurons and the TASK-2 channel in ileum and colon respectively.
TASK-2 displayed cell membrane labeling of NOS-negative cell bodies and axons. Immunoreactivity for the TASK-2 channel was not detectable in α-actinin
immunopositive longitudinal smooth muscle cells in either mouse ileum (C2) or colon (D2). Scale bars represent 10µm.
TREK Family Activators Regulate the Force
but Not Frequency of Spontaneous
Contractions
Previous reports have revealed an important stretch-activated
K+ conductance SDK in colonic smooth muscle cells that
bares all the hallmarks of a background TREK-like channel
current (Koh and Sanders, 2001; Koh et al., 2001; Park
et al., 2005). However, direct pharmacological evidence for
the specific involvement of mechano-gated K2P subfamily
channels in ileum and colon smooth muscle contractility is
pauce.
To investigate whether the activation of mechano-gated K2P
channels influences physiological intestinal contractions, we
applied the antidepressant drug Riluzole and the cyclooxygenase
(COX) inhibitor BL-1249 to isolated mouse ileum and colon
segments using the organ bath system and measured changes
in the force and frequency of spontaneous contractions. Both
Riluzole and BL-1249 have been shown to be potent activators of
the mechano-gated K2P channels TREK-1, TREK-2, and TRAAK
(Duprat et al., 2000; Veale et al., 2014). Riluzole (100µM),
significantly decreased the force of spontaneous contractions
in ileum (0.19 ± 0.04 g vs. 0.07 ± 0.01 g, n = 6, p <0.05,
Student’s paired t-test, Figure 6A2) and in colon (0.07 ± 0.01 g
vs. 0.03 ± 0.01 g, n = 6, p < 0.01, Student’s paired t-test,
Figure 6B2) and produced a noticeable reduction in basal tone
as illustrated in the exemplar traces shown in Figures 6A1,B1.
Likewise, addition of BL-1249 (30µM) significantly reduced the
force of spontaneous contractions in ileum (0.14 ± 0.02 g vs.
0.06± 0.01 g, n= 6, p<0.01, Student’s paired t-test, Figure 6C2)
but not colon (0.06 ± 0.02 g vs. 0.05± 0.02 g, n = 6, p = 0.09,
Student’s paired t-test, Figure 6D2) as shown in Figures 6C1,D1
FIGURE 3 | TREK-1 channel are expressed in longitudinal smooth
muscle (LM) tissue of both mouse ileum and colon. (A3,C) (ileum) and (B3,D)
(colon) show overlays of cell specific markers (green) and the TREK-1 channel
marker (red). For clarity, (A1,A2) (ileum) and (B1,B2) (colon) show individual
images from corresponding positive merges in smooth muscle. Within the
longitudinal smooth muscle layer, TREK-1 channels were distributed in
α-actinin-immunopositive smooth muscles in both ileum (A3) and colon (B3).
(C,D) show overlays for NOS immunoreactive myenteric plexus (MP) neurons
and the TREK-1 channel in ileum and colon respectively. A signal
corresponding to the TREK1 channel subunit was not detected in neuronal
tissue of either ileum or colon. Scale bars represent 10µm.
respectively. Neither Riluzole nor BL-1249 had any significant
effect of the frequency of spontaneous contractions in ileum or
colon (Figures 6A3,B3,C3,D3).
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FIGURE 4 | TREK-2 channels are expressed in myenteric plexus (MP) neurons
of both mouse ileum and colon. (A,C3) (ileum) and (B,D3) (colon) show
overlays of cell specific markers (green) and the TREK-2 channel marker (red).
For clarity, (C1,C2) (ileum) and (D1,D2) (colon) show individual images from
corresponding positive merges in enteric neurons. Within the longitudinal
smooth muscle (LM) layer, the TREK-2 channel signal was weak and barely
detectable in α-actinin immunopositive smooth muscle cells in both ileum (A)
and colon (B). (C3,D3) show overlays for NOS immunoreactive myenteric
plexus neurons and the TREK-2 channel in ileum and colon respectively.
TREK-2 channels appear to be distributed in both NOS-positive and
NOS-negative enteric neurons. Scale bars represent 10µm (A,B) and 20µm
(C1–C3,D1–D3).
Pharmacological Activation of TREK
Family Channels Induces Relaxation in
Carbachol Pre-contracted Ileum and Colon
Given the clear physiological effects of pharmacological
activation of mechano-gated K2P channels on ileum and colon
contractile activity, we decided to probe the impact of K2P
channel activation in pre-contracted tissues, employing the
organ bath system to directly monitor changes in both ileum
and colon muscle tension during application of a range of
specific mechano-gated K2P activators including the fenamate
flufenamic acid (FFA), the lipoxygenase inhibitor cinnamyl
1-3,4-dihydroxy-alpha-cyanocinnamate (CDC) (Danthi et al.,
2004; Veale et al., 2014) and the previously utilized compounds
Riluzole and BL-1249.
Isolated ileum and colon segments were pre-contracted with
the parasympathomimetic drug Carbachol (CCh, 10µM) and
the generated tension allowed to reach steady state before the
addition of K2P activators (Figures 7A1,B1). Changes in tension
induced by addition of activators were normalized to steady-
state pre-contracted tension in each individual experiment and
are reported as percent. On average 10µM CCh generated a
tension of 1.2 ± 0.03 g in ileum and 1.3 ± 0.05 g in colon
(both n = 100). Bath exposure to the caffeic acid derivative and
lipoxygenase inhibitor CDC produced a relaxation in ileum, the
magnitude of which was concentration dependent (IC50 = 8.5
± 1.0µM, Figure 7A2), resulting in a 88.5 ± 1.2% relaxation
FIGURE 5 | TRAAK channels are expressed in myenteric plexus (MP) neurons
of both mouse ileum and colon. (A,C3) (ileum) and (B,D3) (colon) show
overlays of cell specific markers (green) and the TRAAK channel marker (red).
For clarity, (C1,C2) (ileum) and (D1,D2) (colon) show individual images from
corresponding positive merges in enteric neurons. Within the longitudinal
smooth muscle (LM) layer, the TRAAK channel signal was weak and barely
detectable in α-actinin immunopositive smooth muscle cells in both ileum (A)
and colon (B). (C3,D3) show overlays for NOS immunoreactive myenteric
plexus neurons and the TRAAK channel in ileum and colon respectively.
TRAAK channels appear to be distributed in the cytoplasm of both
NOS-positive and NOS-negative enteric neurons. Scale bars represent 20µm
(A,B,C1–C3) and 40µm (D1–D3).
at 30µM (illustrated in the exemplar trace in Figure 7A1).
Relaxation to CDC in colon was also concentration dependent
(IC50 = 18.6 ± 3.5µM, Figure 7A2), however the relaxations at
all effective concentrations were significantly smaller than those
observed in ileum, only reaching amaximally observed relaxation
of 57.1 ± 3.4% at 60µM CDC (Figure 7A2). We suggest the
relaxation induced by CDC did not occur through inhibition
of lipoxygenase, as application of an alternative lipoxygenase
inhibitor, Zileuton (10µM), did not induce a significant change
in tension in either CCh pre-contracted ileum (4.8± 1.3%, n= 6,
p = 0.70, Student’s paired t-test) or colon (6.2 ± 1.4%, n = 6,
p= 0.058, Student’s paired t test) as shown in Figure 7A2 inset.
Similar to CDC, the TREK family activator and COX
inhibitor BL-1249 induced a concentration dependent decrease
in muscle tension in both CCh pre-contracted ileum and colon
(Figure 7B2) with a predicted IC50 of 13.7 ± 1.4µM (ileum,
n = 6) and 60.8 ± 4.2µM (colon, n = 6). Although relaxation
induced by the highest concentration of BL-1249 used (60µM)
was not maximal, it differed significantly between ileum and
colon tissues (93.1 ± 1.2% vs. 56.1 ± 4.2% respectively, n = 6,
p < 0.0001, two-way ANOVA followed by a Bonferroni multiple
comparisons test). The activity of BL-1249 as a K2P activator was
likely direct and not through accumulation of arachidonic acid
induced by inhibition of COX enzymes, as application of the
broad spectrum COX-inhibitor aspirin (100µM) did not cause a
significant change in tension in either CCh pre-contracted ileum
(5.3 ± 1.6%, n = 6, p = 0.88, Student’s paired t-test) or colon
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FIGURE 6 | Activation of mechano-gated K2P channels by Riluzole and BL-1249 reduces the force but not frequency of spontaneous contractions in mouse ileum
and colon. Spontaneous contractions were recorded in the presence and absence of 100µM Riluzole (A,B) and 30µM BL-1249 (C,D) in ileum (left) and colon (right)
as indicated. Upper panels, representative traces show the effects of 100µM Riluzole on the spontaneous contractile responses obtained from mouse ileum (A1) and
colon (B1). Arrows signify reduction in basal tone. Mean data for force of contraction and frequency is displayed in chart form below the corresponding traces for
ileum (A2,A3) and for colon (B2,B3). Lower panels, representative traces show the effects of 30µM BL-1249 on the spontaneous contractile responses obtained
from mouse ileum (C1) and colon (D1). Arrows signify reduction in basal tone. Mean data for force of contraction and frequency is displayed in chart form below the
corresponding traces for ileum (C2,C3) and for colon (D2,D3). For traces, scale bars represent 0.2 g (vertical) and 30 s (horizontal) for (A1,C1), and 0.1 g (vertical) and
30 s (horizontal) for (B1,D1). For bar charts, error bars represent standard deviation (SD); n = 6 animals. *P < 0.05, **P < 0.01, paired t-test.
(2.0± 2.3%, n= 6, p= 0.95, Student’s paired t-test) as shown in
Figure 7B2 inset.
Single concentration additions of the related fenamate,
flufenamic acid (FFA), and the antidepressant drug Riluzole also
induced marked relaxations in CCh pre-contracted ileum and
colon tissues, although to a lesser degree than those observed
with BL-1249 and CDC [Figure 7C; FFA, 63.3 ± 6.2% (ileum)
and 41.1 ± 3.4% (colon); Riluzole, 37.1 ± 4.7% (ileum) and
18.9 ± 4.0% (colon)]. Consistent with our data obtained with
CDC and BL-1249, the observed relaxations to FFA and Riluzole
were significantly greater in ileum vs. colon (Figure 7C, n = 6,
p< 0.05, Student’s unpaired t-test).
Relaxation Induced by TREK-1 Activator
BL-1249 Can Be Attenuated by Barium
There is currently a lack of well tested, specific TREK-1 inhibitors,
however the non-selective potassium channel pore blocker
barium chloride (Ba2+) has been shown to effectively inhibit
TREK-1 channels with an IC50 of ∼1mM (Ma et al., 2011).
We therefore tested the ability of the TREK-1 activator BL-1249
to relax CCh pre-contracted ileum and colon in the presence
of 1mM Ba2+. As would be predicted, addition of 1mM Ba2+
significantly attenuated the relaxatory response to BL-1249 in
both ileum (Figure 7E1) and colon (Figure 7E2). In ileum,
10µM BL-1249 induced a mean normalized relaxation of 63.2
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FIGURE 7 | Pharmacological activation mechano-gated K2P channels relaxes CCh and KCl pre-contracted mouse ileum and colon tissues. Top, representative
traces showing the time course of the addition of mechano-gated K2P channel activators 30µM CDC (A1) and 60µM BL-1249 (B1) to mouse ileum, pre-contracted
with 10µM carbachol (CCh). Scale bars represent 0.4 g (vertical), and 1min (horizontal). Mean concentration-response relationships in CCh pre-contracted ileum
(black circles) and colon (gray triangles) for Cinnamyl 1-3,4-dihydroxy-alpha-cyanocinnamate (CDC) (A2) and the fenamate BL-1249 (B2) are shown below the
corresponding traces. All data was fitted with non-linear regression giving predicted IC50’s of CDC (8.5 ± 1.0µM in ileum vs. 18.6 ± 3.5µM in colon); BL-1249 (13.7
± 1.4µM in ileum vs. 60.8 ± 4.2µM in colon). (A2) inset, mean normalized relaxation in CCh pre-contracted ileum (black bar) and colon (gray bar) to Zileuton (10µM).
(B2) inset, mean normalized relaxation in CCh pre-contracted ileum (black bar), and colon (gray bar) to aspirin (100µM). (C,D) mean normalized relaxation of CCh
(C) and KCl (D) pre-contracted ileum (black bars) and colon (gray bars) by Riluzole (100µM), BL-1249 (30µM), fluflenamic acid (FFA) (100µM) and CDC (30µM).
Error bars represent standard deviation (SD). Lower panels, (E1) mean normalized relaxation in ileum to 10µM BL-1249 in the absence (gray bar) and presence (white
bar) of 1mM barium chloride (Ba2+), (E2) mean normalized relaxation in colon to 30µM BL-1249 in the absence (black bar) and presence (white bar) of 1mM barium
chloride (Ba2+). All data represents n = 6 animals. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA followed by the Bonferroni post-hoc test
(A2,B2), unpaired t-test (C,D), paired t-test (E1,E2).
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± 5.3% which was reduced to 32.1 ± 3.1% in the presence
of Ba2+ (p = 0.0003, Student’s paired t-test). A similar effect
was observed in colon were 30µM BL-1249 induced a mean
normalized relaxation of 42.8 ± 2.1% compared to 29.9 ± 2.4%
in the presence of 1mM Ba2+ (p = 0.0143, Student’s paired
t-test). Furthermore, under basal conditions in the absence of
pre-contraction, 10mM Ba2+ was able to induce significant
contractile responses in both ileum (1.1± 0.1 g, n= 6) and colon
(0.5± 0.1 g, n= 6).
Relaxation by Mechano-Gated K2P
Activators Occurs via Smooth Muscle
TREK-1 Channels
Data from these functional studies demonstrate a clear
contribution of TREK-like channels to GI tract smooth muscle
contractility, however it is uncertain whether the relaxations
observed with the K2P activators occurred at the level of the
smooth muscle (via TREK-1) or through modulation of neuronal
input (via TREK-2/TRAAK). To clarify this, we performed drug
additions (1) in tissues pre-contracted with potassium chloride
(60mM KCl) and (2) in tissues pre-contracted with CCh in the
presence of tetrodotoxin (TTX), a voltage-gated sodium channel
blocker, which in this preparation will block neuronal action
potentials and prevents ENS activity (Seifi et al., 2014).
Isolated ileum and colon segments were pre-contracted
with 60mM KCl and the generated tension allowed to reach
steady state before the addition of K2P activators. Changes
in tension induced by addition of TREK-1 activators were
normalized to steady-state pre-contracted tension in each
individual experiment and are reported as percent. On average
60mM KCl generated a tension of 0.6 ± 0.04 g in ileum and
0.8 ± 0.05 g in colon (both n = 50). All mechano-gated K2P
channel activators (Riluzole, BL-1249, FFA, and CDC) induced
robust relaxations of KCl pre-contracted ileum and colon tissues
(Figure 7D) with BL-1249 and FFA producing significantly
greater magnitudes of relaxation in ileum compared to colon
(n = 6, p = <0.05, Student’s unpaired t-test). In ileum, the
extent of the relaxation induced by BL-1249, FFA, and CDC was
independent of the manner of pre-contraction, however Riluzole
produced a significantly greater relaxation when the ileum was
pre-contracted with KCl compared to CCh (72.1 ± 3.6 vs. 37.1
± 3.9%, n = 6, p = <0.0001, Student’s unpaired t-test). This
phenomenon was similarly observed in colon with Riluzole (78.3
± 5.2%, KCl vs. 18.9 ± 4.4%, CCh, n = 6, p < 0.0001, Student’s
unpaired t-test) and CDC (76.2± 6.9% in KCl vs. 57.1± 3.3% in
CCh, n = 6, p=<0.01, Student’s unpaired t-test).
These data are consistent with a direct smooth muscle effect.
To reinforce this hypothesis we assessed the effects of a K2P
activator in the presence of tetrodotoxin (TTX). TTX is a voltage-
gated sodium channel blocker, which in this preparation will
block neuronal action potentials and therefore prevent ENS
activity (Seifi et al., 2014). The relaxation of CCh pre-contracted
tissues induced by BL-1249 (60µM) persisted in the presence
of TTX (1µM); in ileum, 91.1 ± 2.0% (without TTX) vs. 98.2
± 3.7% (with TTX), n = 6, p = 0.038, Student’s paired t-
test; in colon, 63.6 ± 2.9% (without TTX) vs. 64.8 ± 5.0%
(with TTX), n = 6, p = 0.74, Student’s paired t-test (data not
illustrated).
Overall, these data suggest that the relaxation induced by
activation of mechano-gated K2P channels is independent of
enteric neuron input and therefore likely occurs at the level of
the smooth muscle via activation of TREK-1 channels.
DISCUSSION
Our understanding of the expression profiles and functional roles
of K2P channels, particularly in smooth muscle tissue of the
gastrointestinal tract is rather limited. This is largely due to a
paucity of K2P channel specific pharmacological tools. However,
of the K2P channels described to date, the mechano-gated
TREK subfamily of K2P channels are appearing as important
regulators of smooth muscle contractility (Parelkar et al., 2010;
Lembrechts et al., 2011; Monaghan et al., 2011; Lei et al., 2014)
and importantly, details of several activators and inhibitors for
this subfamily are emerging (Vivier et al., 2016). Previous studies
have indicated that TREK-like channels underlie a stretch-
dependant conductance in colonic smooth muscle cells, based
on the biophysical phenotype and similarity to cloned murine
TREK-1 channels, including mechano-sensitivity, insensitivity
to classical potassium channel blockers, and regulation by
nitrergic stimulation (Koh and Sanders, 2001; Koh et al., 2001;
Park et al., 2005). However, direct pharmacological support
for this hypothesis is sought. In this study we show TREK-
1, TREK-2, and TRAAK channels are differentially expressed
in murine ileum and colon, with TREK-1 channels displaying
a primarily smooth muscle cell expression with TREK-2 and
TRAAK limited to enteric neurons. Furthermore, we present
clear pharmacological evidence for a functional role for TREK-1
in determining gastrointestinal contractility.
Evidence for the expression of K2P channels in the
gastrointestinal system is poor, with transcript profiles restricted
to the TASK and TREK subfamilies. In this study we performed
the first, whole family profiling of K2P channel mRNA in
the gastrointestinal tract. Our data showed robust transcript
expression for multiple K2P channels including TWIK-1, TASK-
1, TASK-2, and TREK-1. The profiles of K2P channel mRNA
was comparable across ileum and colon, at least at the whole
tissue level. A caveat to our transcript profiling was that mRNA
levels were assessed in whole tissues and could not differentiate
between the proportions within different cell types present in
the GI tract (smooth muscle, neuron, glia, epithelia). Hence, the
low level expression of some K2P channel transcripts including
TREK-2 and TRAAK likely represented discrete, cell specific
expression profiles. Our data echoed previous RT-PCR studies,
where TREK-1 (KCNK2), TASK-1 (KCNK3), TASK-2 (KCNK5),
and TASK-3 (KCNK9) mRNA have been detected in colonic
muscle tissue (Koh et al., 2001; Cho et al., 2005; Kubota
et al., 2015). However, a novel finding from our qPCR was the
high expression of TWIK-1 (KCNK1) and TASK-2 (KCNK5)
mRNA in both ileum and colon. Detailed immunohistochemical
analysis for these proteins demonstrated a wide distribution
pattern across smooth muscle and neuronal cell types in
ileum and colon and may be suggestive of important roles in
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gastrointestinal physiology. Indeed Cho et al. (2005) previously
highlighted TASK-2 expression in murine colon and a TASK-2-
like conductance as a potential contributor to resting membrane
potential, although the pharmacological tools used to assess
this (lidocaine) were used at concentrations too high to be
TASK-2 specific. Along with a current lack of pharmacological
tools for TWIK-1, the physiological importance of these two
channels in the gastrointestinal system remains to be conclusively
determined.
However, a physiological role of a mechano-gated K2P
channel has been proposed, and biophysical characteristics
and transcript expression profile point toward TREK-1 as
the molecular correlate of the SDK conductance in colonic
myocytes (Koh and Sanders, 2001), although direct protein
localization and conclusive pharmacological evidence was
needed. Immunohistochemical analysis of all three mechano-
gated K2P channel proteins in the murine GI tract revealed a
distinct expression pattern of these channels. We found evidence
for TREK-1 channel expression in longitudinal and circular
smooth muscle tissues, but not in nitrenergic enteric neurons of
the myenteric and submucosal plexuses, whereas TREK-2 and
TRAAK channel proteins were only observed in enteric neurons
and were not detected in smooth muscle layers. This distinctive
expression pattern is analogous to previous observations in
airway (Lembrechts et al., 2011) and bladder (Lei et al., 2014) and
contrasts their expression in the central nervous system where
they show overlapping expression in a variety of neurons where
they are thought to form functional heterodimers (Blin et al.,
2016). That TREK-1 is expressed in smooth muscle and not
neurons in the gut suggests a specific role for this channel in
gastrointestinal physiology.
In support of our immunohistochemical findings we sought
further pharmacological evidence for mechano-gated K2P
functional expression in murine ileum and colon using an organ
bath preparation. Previously, a proposed TREK inhibitor, L-
methionine, was used to suggest the functional presence of
TREK channels in colonic myocytes (Park et al., 2005). However,
it has since been argued that the effects of L-methionine
in native tissue do not involve TREK-1 (Gil et al., 2012).
Indeed, in the same study, the authors utilized a TREK-1
blocker, spadin, and observed no effect on colonic membrane
potential or spontaneous motility. Given the lack of clarity
and deficiency of alternative specific TREK channel inhibitors,
we therefore assessed the repolarizing power of established
mechano-gated K2P channel activators in pre-contracted tissues
and on spontaneous activity to assay the contribution of TREK
channels to intestinal contractility. The approach yielded strong
evidence for a functional role of smooth muscle TREK-1 in
murine gastrointestinal tract, both under basal conditions and
during pre-contraction.
In order to provide evidence that the relaxatory effect of
the activators originated at the level of the smooth muscle
we pre-contracted with potassium chloride. In the case of
Riluzole, the relaxatory effect was stronger than that previously
observed with CCh pre-contraction. This differential effect
could be explained by activation of enteric neurons which
would counteract the relaxatory response at the smooth
muscle. This would also provide an explanation for the
enhanced relaxation to BL-1249 observed during TTX blockade.
Alternatively, the mechanism of pre-contraction could also
be influential. Carbachol, a parasympathomimetic, activates
metabotropic muscarinic receptors inducing contraction via:
(1) transmembrane calcium influx through TRPC channels, (2)
subsequent transmembrane calcium influx via VDCC, and (3)
SR calcium release (Ambudkar, 2009). When using KCl as the
contractile stimulus, only transmembrane calcium influx via
VDCC occurs and calcium influx through TRPC channels and
SR calcium release would not occur. Thus, the use of TREK-
1 activators would be expected to modulate the membrane
potential driven calcium influx through VDCC (receptor
independent) and therefore might appear less efficacious in CCh
pre-contracted tissues.
Available data suggests all utilized compounds are potent
activators of mechano-gated TREK channels. Riluzole has been
shown to directly activate TREK-1, TREK-2, and TRAAK
channels (Duprat et al., 2000), and CDC to activate TREK-1
(Danthi et al., 2004). Fenamates, non-steroid anti-inflammatory
drugs, including BL-1249 and FFA (flufenamic acid) have been
revealed to directly and reversibly activate TREK-1, TREK-
2, and TRAAK channels (Takahira et al., 2005; Veale et al.,
2014) but have also been reported to activate a number of
other potassium channels (for review see Guinamard et al.,
2013). All four compounds produced comparable effects on
pre-contracted ileum and colon tissues and have previously
been used to describe functions of mechano-gated K2P channels
in native tissues including sympathetic neurons (Cadaveira-
Mosquera et al., 2011) dorsal root ganglion cells (Han
et al., 2016), the blood brain barrier (Bittner et al., 2013),
bladder (Tertyshnikova et al., 2005), and adrenocortex (Enyeart
et al., 2002; Danthi et al., 2004). However, in order to
further reinforce the suggestion that the observed relaxation
occurs via activation of TREK-1 channels, we investigated
the impact of a known, but not specific, TREK-1 inhibitor,
barium, on the ability of the TREK-1 activator BL-1249
to induce relaxation in both ileum and colon. Barium was
chosen due to a lack of suitable alternative TREK-1 blockers.
Spadin is a proposed TREK-1 inhibitor (Mazella et al.,
2010), however, mechanistically it is an antagonist and not a
classical blocker, and does not block TREK-1 currents under
basal conditions but rather prevents activation (Moha Ou
Maati et al., 2012). The specific molecular mechanism of
action of spadin has not been described and its ability to
prevent TREK-1 activation by Riluzole, FFA, CDC, and BL-
1249 has not yet been established or confirmed. Fluoxetine
is another potent blocker of TREK-1 (Kennard et al., 2005),
however its activity as a serotonin (5-hyroxytryptamine)
reuptake inhibitor would modulate contractile activity in
the gastrointestinal tract through mechanisms independent of
TREK-1 and therefore precluded its use. Although not specific,
the IC50 for TREK-1 block by barium is ∼1mM (Ma et al.,
2011). Pre-exposure of ileum and colon tissues to 1mM barium
attenuated the relaxatory response to the TREK-1 activator,
BL-1249, by 50 and ∼30% respectively, in line with what
might be predicted. This provides further support for the
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suggestion that BL-1249 likely relaxes the gastrointestinal smooth
muscle via TREK-1 activation.
Taken together these data provide the only pharmacological
evidence to date for a functional role for TREK-1
channels in intestinal contractility, and coupled with clear
molecular and protein expression profiles, could have
potential therapeutic implications for treating motility
disorders arising from hyper-contractility, such as irritable
bowel syndromes.
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